Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BM2216
- Development stage
- Phase 1
- Lead developer
- Nanjing Baimai Biotechnology
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
BM2216 is an extended-release small molecule drug under development for the treatment of diabetic neuropathies and other nervous system disorders. It was initially developed by Nanjing Baimai Biotechnology and is being further developed by Zhejiang Anglikang Pharmaceutical. The drug is currently in Phase 1 clinical trials. Its mechanism of action has not been explicitly detailed in public sources, but based on its comparison to melogabalin besilate in clinical studies and its therapeutic area, it is likely a gabapentinoid or related compound targeting neuropathic pain pathways[1][2][3][4][8].
Beyond the preview
Go deeper on BM2216.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BM2216.